Diabetes Darrow Flashcards
granuloma annulare
type IV rxn
associated with diabetes, thyroid disease, infection, malignancy, drugs
metabolic syndrome
2 physical findings
-waist circumference and HTN
3 lab findings
-triglycerides, HDL-C, and glucose
apple
bad body shape
-want to be a pear
adipose tissue
secretes inflammatory and immune mediators
-adipokines
abdominal fat
vs. subQ
causal factor mediating insulin resistance, increased diabetes risk, and cardiovascular disease in metabolic syndrome
dysregulated adipokine secretion, FFA toxicity, macrophage infiltration
obese inflamed fat
release of adipokines
low levels of adiponectin
has lots of macrophages
with obesity and insulin resistance
this can promote ectopic lipid accumulation
lean person adipose tissue
few macrophages, high adiponectin, low inflammatory cytokines
TZD
thiazolinediones
activate PPAR
cause insulin resistance, VEGF angiogenesis inhibiton, increased leptin
TSP1
to TGF-beta
to PAI-1 (procoagulant)
to atherosclerosis
with metabolic syndrome
hyperuricemia larger hyperdense LDL increased PAI - atherosclerosis increased platelet adhesion decreased homocysteine
diagnosis of type II DM
random >200 with sx
FBS >126 x2 (pre 100-125)
post meal >200 x2 (pre 140-199)
HBA1C >6.5% x2 (pre 5.7-6.4)
causes of DM II
genetic - beta cell fatigue and death
-TCF7L2 - transcription factor in beta cell development
environmental - visceral obesity - insulin resistance
TCF7L2
genetic mutation in DM II
Wnt signaling pathway - for beta cell development
vitiligo in DM I?
autoimmune - so see mix of sx
polyuria
C-DRIPPED
cortisol excess DM recovery from renal failure ions (hyper Ca, hypo K) parkinsons - nocturnal nocturia psychogenic polydipsia enzyme drugs
Abs in DM I
GAD 65 insulin Abs islet cell cytoplasmic Abs insulinoma associated 2 zinc transporter Abs tyrosine phosphatase Abs
HLA in DM I
DR3 and DR4
MODY
maturity onset diabetes of youth
defect in TFHNF1
-results in decreased apoM**
decreased clearance of HDL
acanthosis nigricans
sign of insulin resistance
-DM II
TFHNF1
with MODY
no apoM - so HDL is high
most common MODY
type 3
do respond to sulfonylureas
MODY syndromes
involve impaired glucose induced secretion of insulin
high E and NE
decrease insulin secretion
- due to alpha2 adrenergic activation
- result in hyperglycemia
cause of insulin resistance
obesity and hyperglycemia
all proteins get glycated
drugs causing hyperglycemia
beta blockers glucocorticoids antipsychotic - olanzapine statins oral contraceptives pentamidine cyclosporine niacin
TNF alpha
blocks effects of insulin
-muscle, liver, fat
problem of obesity in DM II
muscle insulin resistance
excess calories - lipogenesis with excess malonyl CoA - blockage of fatty acyl CoA oxiation
byproducts - DAG and ceramide
ceramide activates PKC pathways - inhibit insulin receptor activity
eruptive xanthoma
hepatic overproduction of VLDL (type 4)
associated with diabetes
cheiropathy
limited joint mobility
can’t prayer sign hands
with diabetes
coronary artery disease equivalents
DM
cerebral arterial disease
aortic aneurysm
PVD
most diabetics
on statins - coronary artery disease equivalent
type IIb hyperlipidemia
increased heaptic secretion of apoB100 and VLDL
no xanthomas
hypoglycemia
insulinoma
whipples triad
insulinoma if:
1 signs and sx of hypoglycemia
2 low glucose at time of event (<50)
3 reversal with correction of hypoglycemia
sympathoadrenal signs
glucose <60
sweating, tachycardia, tachypnea, anxiety, tremors, nausea
more with post-prandial
neuroglycopenic signs
glucose <50
blurry vision, fatigue, dizzy, HA, seizure, confused, coma, death
more with fasting
diagnosis of insulinoma
72 hour fast
with insulin and glucose measure
insulinomas
80% are benign pancreatic adenoma
tx - surgery
diazoxide
opens K channels - to stop insulin secretion in insulinoma
in hypoglycemia
should see low glucose and low insulin
C-peptide present in hypoglycemia
taken sulfonylurea drug**
C peptide absent
taken too much insulin**
nesidioblastoma
noninsulinoma pancreatogenous hypoglycemia syndrome
pancreatic cell hyperplasia
post prandial hypoglycemia